Skip to main content
Clinical Trials/NL-OMON43968
NL-OMON43968
Withdrawn
N/A

Metabolic parameters in paediatric patients with autism spectrum disorders (ASD) with and without antipsychotic medication. Prevalence, incidence and riskfactors. - Metabolic parameters in paediatric patients with ASD.

GGZ Centraal (Amersfoort)0 sites112 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
autism
Sponsor
GGZ Centraal (Amersfoort)
Enrollment
112
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
GGZ Centraal (Amersfoort)

Eligibility Criteria

Inclusion Criteria

  • Paediatric patients aged between 6 and 18 years with a DSM\- IV\-TR diagnosis of ASD with and without an indication for treatment with antipsychotic medication. Co\-medication like stimulants or SSRI\*s is allowed. Patients on antipsychotic medication will start with this medication and have to be antipsychotic\-naïve.

Exclusion Criteria

  • History of treatment with antipsychotic medication (ASD group without antipsychotic medication)
  • Treatment with more than 1 SGA
  • Active or past eating disorder
  • Biochemical evidence of thyroid dysfunction/diabetes mellitus.
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials